动机性访谈与空气净化器对吸烟慢阻肺患者的影响:MOVE随机双盲安慰剂对照试验
这项随机双盲安慰剂对照试验纳入121例中重度慢阻肺现吸烟者,评估便携式高效空气净化器联合动机性访谈减少室内颗粒物(PM)和二手烟(SHS)暴露对呼吸健康的影响。结果显示活性干预组PM水平降低但SHS暴露未减少,圣乔治呼吸问卷总分较对照组显著改善(β -4.4,95%CI -8.2至-0.5;
要点
- 便携式高效空气净化器联合动机性访谈可降低室内PM水平,但未减少二手烟暴露。
- FEV1变化、痰液症状及急性加重风险两组间无显著差异。
核心结论
- 该研究首次证明对慢阻肺现吸烟者进行环境干预可能带来健康获益,最可能归因于便携式高效空气净化器使用相关的PM减少。
研究设计与样本
- 随机、双盲、安慰剂对照试验,纳入121例中重度慢阻肺现吸烟者,随机接受活性便携式高效空气净化器联合动机性访谈或假净化器无动机性访谈,99例完成研究。
主要发现
- 活性干预组PM水平较对照组降低,但室内SHS暴露未减少。
- 活性组呼吸困难、咳嗽症状及COPD评估测试和临床COPD问卷所测健康状态显著改善。
- 两组间FEV1变化、痰液症状或急性加重 odds 无显著差异。
临床怎么用
- 对中重度慢阻肺现吸烟者,可考虑使用便携式高效空气净化器联合动机性访谈以降低室内PM并改善呼吸相关生活质量。
局限性
- 样本量有限(121例随机,99例完成),可能影响次要结局的检验效能。
- 干预未能减少室内SHS暴露,限制了对二手烟暴露相关结局的解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Indoor particulate matter (PM) is linked to worse respiratory outcomes in adults with chronic obstructive -pulmonary disease (COPD). It is unclear if reducing indoor pollutants can improve respiratory health among current smokers. OBJECTIVE: This study aimed to assess whether a multicomponent environmental intervention to improve home air quality (PM and secondhand smoke [SHS] exposure) improves respiratory morbidity among current smokers with COPD. METHODS: Current smokers with moderate-to-severe COPD were randomized to receive active portable high-efficiency -particulate air cleaners and motivational interviewing (MI) for PM and SHS reduction, respectively; or sham air cleaners -without MI. The primary outcome was 6-month change in Saint George's Respiratory Questionnaire. Secondary outcomes were respiratory symptoms, exacerbation risk, and lung function. MAIN RESULTS: Among 121 randomized participants, 99 completed the study. The active intervention resulted in reduced PM levels compared to control, but no reduction in indoor SHS exposure. Those in the active arm showed a clinically and statistically significant improvement in total Saint George's Respiratory Questionnaire score compared to control (ß -4.4 [95% confidence interval, -8.2 to -0.5]; P = .025). Secondary analyses indicated significant improvement in respiratory symptoms (dyspnea and cough) and health status as measured by COPD Assessment Test and clinical COPD questionnaire among the active group (vs. control). There was no significant difference in forced expiratory volume in 1 second change, sputum symptoms, or odds of exacerbations between groups. CONCLUSIONS: This study is the first to demonstrate potential health benefits from an environmental intervention in active smokers with COPD, most likely attributable to PM reduction associated with portable high-efficiency particulate air cleaner use.
引用
- Hansel, Putcha, Woo, et al. Motivational interviewing and air cleaners for smokers with COPD (MOVE): a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med. 2026. PMID: 41738215. doi:10.1093/ajrccm/aamag016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。